GB virus C/hepatitis G virus - Discovery, epidemiology, diagnosis and clinical significance;GB-virus-C/hepatitis-G-virus - Entdeckung, epidemiologie, diagnostik und klinische relevanz

Zeitschrift fur Gastroenterologie

Volumn 36, Issue 11, 1998, Pages 997-1007

  Sarrazim, Chr ^a   Roth, W K ^b   Zeuzem, S ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Inst F Transfusionsmedizin I   (Germany)

Author keywords

GB virus C; Hepatitis; Hepatitis G virus; Non A E

Indexed keywords

AMINOTRANSFERASE; VIRUS RNA;

FLAVIVIRUS; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; OPEN READING FRAME; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SUPERINFECTION; VIRUS CLASSIFICATION; VIRUS GENOME; VIRUS HEPATITIS; VIRUS TRANSMISSION;

CROSS-SECTIONAL STUDIES; FLAVIVIRIDAE; HEPATITIS, VIRAL, HUMAN; HUMANS; INCIDENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL;

EID: 0031733312     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Purcell RH. The discovery of the hepatitis viruses. Gastroenterology 1993; 104: 955-63
2. Evans AS. Attempts to transmit the virus of human hepatitis to primates other than man. Nat Acad Sci-Nat Res Council, Publ 1954; 322: 58
3. Deinhardt F, Holmes AW, Capps RB, Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med 1967; 125: 673-88
4. Parks WP, Melnick JL, Voss WR et al. Characterization of marmoset hepatitis virus. J Infect Dis 1969; 120: 548-59
5. Deinhardt F, Peterson D, Cross G, Wolfe L, Holmes AW. Hepatitis in marmosets. Am J Med Sci 1975; 270: 73-80
6. Tabor E, Peterson DA, April M, Seeff LB, Gerety RJ. Transmission of human non-A, non-B hepatitis to chimpanzees following failure to transmit GB agent hepatitis. J Med Virol 1980; 5: 103-8
7. Karayiannis P, Petrovic LM, Fry M et al. Studies of GB hepatitis agent in tamarins. Hepatology 1989; 9: 186-92
8. Schlauder GG, Dawson GJ, Simons JN et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 1995; 46: 81-90
9. Simons JN, Pilot-Matias TJ, Leary TP et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-5
10. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1995; 259: 946-51
11. Roth WK. GB-Virus C (GBV-C)/Hepatitis G Virus (HGV): ein neuentdecktes Virus mit vielen Unbekannten. Mikrobiologie 1996; 6: 120-6
12. Simons JN, Leary TP, Dawon GJ et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-9
13. Pilot-Matias TJ, Muerhoff AS, Simons JN et al. Identification of antigenic regions in the GB hepatitis viruses GBV-A, GBV-B and GBV-C. J Med Virol 1996; 48: 329-38
14. Simons JN, Desai SM, Mushahwar IK. The GB viruses: Isolation, characterization, diagnosis and ep idemiology. Vir Hepatit Rev 1996; 2: 229-46
15. Linnen J, Wages Jr J, Zhang-Keck Z-Y et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996; 271: 505-8
16. Buckh J. Genetic heterogeneity of hepatitis C virus (HCV). IX Triennial International Symposium on viral Hepatitis and Liver Disease 1996; 59: 19A
17. Simons JN, Desai SM, Schultz DE, Lemon SM, Mushahwar IK. Translation initiation in GB viruses A and C: Evidence for internal ribosome entry and implications for genome organization. J Virol 1996; 70: 6126-35
18. Muerhoff AS, Simons JN, Leary TP et al. Sequence heterogeneity within the 5'-terminal region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol 1996; 25: 379-84
19. Fukushi S, Kurihara C, Ishiyama N et al. Nucleotide sequence of the 5' noncoding region of hepatitis G virus isolated from Japanese patients: Comparison with reported isolates. Biochem Biophys Res Commun 1996; 226: 314-8
20. Egawa K, Yukawa T, Arakawa S et al. Infection with GB virus C in leprous patients in Japan. J Med Virol 1996; 49: 110-14
21. Wu R-R, Mizokami M, Cao K et al. GB virus C/hepatitis G virus infection in southern China. J Infect Dis 1997; 175: 168-71
22. Kao J-H, Chen P-J, Hsiang S-C, Chen W, Chen D-S. Phylogenetic analysis ot GB virus C: Comparison of isolates from Africa, North America, and Taiwan. J Infect Dis 1996; 174: 410-3
23. Leary TP, Muerhoff AS, Simons JN et al. Sequence and genomic organization ot GBY-C: A novel member of the flaviviridae associated with human non A-E hepatitis. J Med Virol 1995; 48: 60-7
24. Muerhoff AS, Lcary TP, Simons JN et al. Genomic organization of GBV-A and GBV-B: Two new members of the Flaviviridae associated with GB-agent hepatitis. J Virol 1995; 69: 5621-30
25. Shao L, Shinzawa H, Ishikawa K et al. Sequence of hepatitis G virus genome isolated from a Japanese patient with non-A-E-hepatitis: Amplification and cloning by long reverse transcription-PCR. Biochem Biophys Res Commun 1996; 228: 785-91
26. Erker JC, Simons JN, Muerhoff AS et al. Molecular cloning and characterization of a GB virus C isolate from a patient with non-A-E hepatitis. J Gen Virol 1996; 77: 2713-20
27. Choo Q-L, Richman KH, Han JH et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451-5
28. Hsieh S-Y, Yang P-Y, Chen H-C, Liaw Y-F. Cloning and characterization of the extreme 5'-terminal sequences of the RNA genomes of GB virus C/hepatitis G virus. Proc Natl Acad Sci USA 1997; 94: 3206-10
29. Kim JP, Fry KE. Molecular characterization of the hepatitis G virus. J Viral Hepat 1997; 4: 77-9
30. Pickering JM, Thomas H, Karayiannis P. Genetic diversity between HGV isolates: Analysis of nucleotide variation in the NS-3 and putative core peptide. J Gen Virol 1997; 78: 53-60
31. Pickering J: Thomas H, Karayiannis P. Predicted secondary structure of the hepatitis G virus and GB virus-A 5' untranslated regions consistent with an internal ribosome entry site. J Viral Hepat 1997; 4: 175-84
32. Seipp S, Wahl R, Selzer S et al. Studies on hepatitis GB-C virus infection in vitro. Hepatology 1996; 24 (suppl. 1): 288A
33. Seipp S, Selzer S, Stremmel W, Theilmann L, Goeser T. Tissue tropism of GB-C virus: RNA detection in tissue samples and in-vitro infections. J Hepatol 1997; 26 (suppl. 1): 187A
34. Madejón A, Fogeda M, Bartolomé J et al. GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic viral hepatitis B, C, and D. Gastroenterology 1997; 113: 573-8
35. Seipp S, Wahl R, Selzer S et al. Screening for GB-C virus negative-strand RNA in human sera. Hepatology 1996: 24 (suppl. 1): 288A
36. Seipp S, Wahl R, Selzer S et al. Prevalence of GB-C virus positive- and negative-strand RNA in human peripheral blood mononuclear cells of GBV-C infected and GBY-C/HCY coinfected patients. Hepatology 1996: 24 (suppl. 1): 288A
37. Krawczynski K, Gallagher M, Speibring J et al. Experimental HGV infection in primates. IX Triennial International Symposium on Viral Hepatitis and Liver Disease 1996; 140: 39A
38. Alter HJ, Nakatsuji Y, Melpolder J et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-54
39. Hwang S-J, Lu R-H, Chan C-Y et al. The role of hepatitis G virus infection in patients with acute post-transfusion hepatitis in Taiwan. Gastroenterology 1997; 112: 1260-4
40. Roth WK, Waschk D, Marx S et al. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion 1997; 37: 651-6
41. Moaven LD, Hyland CA, Young IF et al. Prevalence of hepatitis G virus in Queensland blood donors. Med J Aust 1996; 165: 369-71
42. Feucht H-H, Zöllner B, Polywka S et al. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 1997; 26: 491-4
43. Mphahlele J, Aspinall S, Carman WF. Prevalence of hepatitis G viremia in South Africa. J Hepatol 1997: 26 (suppl. 1): 205A
44. Dawson GJ, Schlauder GG, Pilot-Matias TJ et al. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol 1996; 50: 97-103
45. Vrielink H, Reesink HW, Hermus MC, Cuypers HTM, Lelie PN. Difference in HGV infection in blood donors between a large city and rural districts in a west european country. J Hepatol 1997; 26 (suppl. 1): 215A
46. Lou S, Qiu X, Leitza S et al. GBV-C E2 immunoassays to study prevalence of GBV-C in US blood donors. J Hepatol 1997; 26 (suppl. 1) 86A
47. Wang J-T, Tsai F-C, Lee C-Z et al. A prospective study of transfusion-transmitted GB virus C infection: Similar frequency but different clinical presentation compared with hepatitis C virus. Blood 1996; 88: 1881-6
48. Alter HJ, Nakatsuji Y, Shih JW-K et al. Transfusion-associated hepatitis G virus infection. IX International Symposium on Viral Hepatitis and Liver Disease 1996; 120: 34A
49. Jarvis LM, Davidson F, Hanley JP et al. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-55
50. Feucht H-H, Zöllner B, Polywka S, Laufs R. Vertical transmission of hepatitis G. Lancet 1996; 347: 62 (letter)
51. Pawlotsky JM, Germanidis G, Huraux C et al. Mother-to-infant transmission of GB virus C (GBV-C) and HCV in HCV-infected pregnant women. Hepatology 1996; 24 (suppl. 1) 225A
52. López-Alcorocho JM, Millán A. Garcia-Trevijano ER et al. Detection of hepatitis GB virus type C RNA in serum and liver from children with chronic viral hepatitis B and C. Hepatology 1997; 25: 1258-60
53. Viazov S, Riffelmann M, Sarr S et al. Transmission of GBV-C/HGV from drug-addicted mothers to their babies. J Hepatol 1997; 27: 85-90
54. Lin H-H, Kao J-H, Hsu H-Y et al. Perinatal transmission of GBY-C. IX International Symposium on Viral Hepatitis and Liver Disease 1996; C219: 258A
55. Moaven LD, Tennakoon PS, Bowden DS, Locarnini SA. Mother-to-baby transmission of hepatitis G virus. Med J Aust 1996; 165: 84-5
56. Sarrazin C, Roth WK, Zeuzem S. Heterosexual transmission of GB virus-C/hepatitis G virus infection. Eur J Gastroenterol Hepatol 1997; 9: 1117-20
57. Noguchi S, Sata M, Suzuki H et al. Transmission routes of GBV-C/HGV in HCV hyperendemic area Japan. Gastroenterology 1997; 112: 1348A
58. Persico T, Thiers V, Tuveri R et al. Detection of hepatitis G/GB-C viral RNA but not HCV RNA in the different semen fractions of infected patients. Hepatology 1996; 24 (suppl. 1): 189A
59. Fabris R, Biasin MR, Benedetti P et al. Close association between HCV and HGV in serum, saliva and semen of patients with chronic C active hepatitis (CAH). J Hepatol 1997; 26 (suppl. 1): 89A
60. Dawson GJ, Schlauder GG, Coleman P et al. Prevalence and clinical significance of GBV-C. IX International Symposium on Viral Hepatitis and Liver Disease 1996; 116: 33A
61. Tsuda F, Hadiwandowo S, Sawada N el al. Infection with GB virus (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia. J Med Virol 1996; 49: 248-52
62. Schlüter V, Schmolke S, Stark K et al. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol 1996; 34: 2660-4
63. Leary TP, Muerhoff AS, Simons JN et al. Consensus oligonucleotide primers for the detection of GB virus C in human cryptogenic hepatitis. J Virol Methods 1996; 56: 119-21
64. Muerhoff AS, Simons JN, Erker JC, Desai SM, Mushahwar IK. Identification of conserved nucleotide sequences within the GB virus C 5'-untranslated region: Design of PCR primers for detection of viral RNA. J Virol Methods 1996; 62: 55-62
65. Pilot-Matias TJ, Muerhoff AS, Simons JN et al. Identification of antigenic regions in the GB hepatitis viruses GBV-A, GBV-B, and GBV-C. J Med Virol 1996; 48: 329-38
66. Sato K, Takeshi T, Okamoto H, Miyakawa Y, Mayumi M. Association of circulating hepatitis G virus with lipoproteins for a lack of binding with antibodies. Biochem Biophys Res Commun 1996; 229: 719-25
67. Pilot-Matias TJ, Carrick RJ, Coleman PF et al. Expression of the GB virus C E2 glycoprotein using the semliki forest virus vector system and its utility as a serologic marker. Virology 1996; 225: 282-92
68. Tacke M, Kiyosawa K, Stark K et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349: 318-20
69. Stark K, Bienzle U, Hess G et al. Detection of the hepatitis G virus genome among injection drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174: 1320-3
70. Schleicher S, Chaves RL, Dehmer T et al. Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients. J Med Virol 1996; 50: 71-4
71. Alter MJ, Gallagher M. Morris TT et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997; 336: 741-6
72. Sarrazin C, Herrmann C, Roth WK et al. Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology. J Hepatol 1997; 27: 276-83
73. Fiordalisi G, Zanella I, Mantero G et al. High prevalence of GB virus C infection in a group of Italian patients with hepatitis of unknown etiology. J Infect Dis 1996; 174: 181-3
74. Colombatto P, Randone A, Civitico G et al. Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: A specific liver disease. J Viral Hepat 1996; 3: 301-6
75. Heringlake S, Osterkamp S, Trautwein C et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-9
76. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1996; 346: 1131-2
77. Kao J-H, Chen P-J, Chen D-S. GBV-C in the aetiology of fulminant hepatitis. Lancet 1996; 347: 120 (letter)
78. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet 1996; 347: 1552 (letter)
79. Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan? Lancet 1996; 347: 908 (letter)
80. Moaven L, Angus P, Bowden DS et al. Hepatitis G virus is not the cause of non A-E fulminant hepatitis. IX International Symposium on Viral Hepatitis and Liver Disease 1996; C195: 252A
81. Haydon GH, Jarvis LM, Simpson KJ, Hayes PC, Simmonds P. The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant, presumed viral hepatitis. J Viral Hepat 1997; 4: 45-9
82. Kanda T, Yokosuka O, Ehata T et al. Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction. Hepatology 1997; 25: 1261-5
83. Masuko K, Mitsui T, Iwano K et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-90
84. Hadziyannis S, Rodes J, Bruix J et al. Impact of HBV, HCV, and HGV on hepatocellular carcinomas in Europe: Results of an European concerted action. J Hepatol 1997; 26 (suppl. 1): 139A
85. Kubo S, Nishiguchi S, Kuroki T et al. Poor association of GBV-C viremia with hepatocellular carcinoma. J Hepatol 1997; 27: 91-5
86. Dietrich CF, Lee J-H, Herrmann G et al. Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 1997; 26: 467-72
87. Dietrich CF, Sarrazin C, Teuber G, Caspary WF, Zeuzem S. Perihepatic lymph nodes in patients with chronic hepatitis G and C. Gastroenterology 1997; 112 (suppl.): 1257A
88. Berg T, Dirla U, Naumann U et al. Responsiveness to Interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol 1996; 25: 763-8
89. Bralet M-P, Roudot-Thoraval F, Pawlotsky J-M et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology 1997; 112: 188-92
90. Pawlotsky J-M, Roudot-Thoraval F, Pellerin M et al. GBV-C infection in HCV-infected patients: Epidemiological characteristics, influence on HCV infection and response to interferon alfa therapy. Hepatology 1996; 24 (suppl. 1): 226A
91. Thomas HC, Pickering J. Karayiannis P. Identification, prevalence and aspects of molecular biology of hepatitis G virus. J Viral Hepat 1997; 4 (suppl. 1): 51-4
92. Francesconi R, Giostra F, Ballardini G et al. Clinical implications of GBV-C/HGV infection in patients with rising-db l-quote-left HCV-related chronic hepatitis. J Hepatol 1997; 26: 1165-72
93. Hess G, Kim J, Karayiannis P, Thomas HC, Hadziyannis S. The interaction of HCV with HGV. IX International Symposium on Viral Hepatitis and Liver Disease 1996; 122: 35A
94. Bell H, Simnionds P, Helium K et al. Treatment of infection with hepatitis G virus/GBV-C with interferon alfa. J Hepatol 1997; 26 (suppl. 1) 203A
95. Tanaka E, Alter HJ, Nakatsuji Y et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996; 125: 740-3
96. Sáiz JC, Ampurdanés S, Olmedo E et al. Hepatitis G virus infection in chronic hepatitis C: Frequency, features and response to interferon therapy. J Hepatol 1997; 26: 787-93
97. Karayiannis P, Hadziyannis SJ, Kim J et al. Hepatitis G virus infection: Clinical characteristics and response to interferon. J Viral Hepat 1997; 4: 37-44
98. Guilera M, Ampurdanés S, Olmedo E et al. HGV infection in chronic liver disease. J Hepatol 1997; 26 (suppl. 1): 194A
99. Cianciara J, Stanczak W, Loch T, Radkowski M, Laskus T. Coinfection with hepatitis G virus does not correlate with HBV replication markers in patients with chronic hepatitis B. J Hepatol 1997; 26(suppl. 1) 212A
100. Kao J-H, Chen P-J, Lai M-Y et al. GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer. Gastroenterology 1997; 112: 1265-70
101. Berg T, Naumann LJ, Fukumoto T et al. GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantation. Transplantation 1996; 62: 711-4
102. Pessoa MG, Terrault NA, Ferrell LD et al. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology 1997; 25: 1266-70
103. Fried MW, Khudyakov YE, Smallwood GA et al. Hepatitis G virus coinfection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver disease. Hepatology 1997; 25: 1271-5
104. Berenguer M, Terrault NA, Piatak M et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996; 111: 1569-75
105. Cotler SJ, Gretch DR, Bronner MP et al. Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients. Hepatology 1997; 26: 432-6
106. Kallinowski B, Buhrmann C, Seipp S et al. Infection with hepatitis GB-C virus after orthotopic liver transplantation. Hepatology 1996; 24 (suppl. 1): 289A
107. Hoofnagle JH, Lombardero M, Wei Y et al. Hepatitis G virus (HGV) infection before and after liver transplantation for fulminant hepatic failure (FHF) and cryptogenic cirrhosis. Hepatology 1996; 24 (suppl. 1) 189A
108. Wolff D, Körner MM, Wolff C, Körfer R, Kleesiek K. Transfusion-related hepatitis G virus infections in heart transplant recipients. Transplantation 1996; 62: 1697-1702
109. Skidmore SJ, Collingham KE, Harrison P et al. High prevalence of hepatitis G virus in bone marrow transplant recipients and patients treated for acute leukemia. Blood 1997; 89: 3853-6
110. Fiordalisi G, Bettinardi A, Zanella I et al. GBV-C infection in intravenous drug users with HIV-associated idiopathic thrombocytopenic purpura. IX International Symposium on Viral Hepatitis and Liver Disease 1996; C224: 259A
111. Mattioli S, Raza T, Imberti L et al. Anti GBV-C antibodies in IIIV+ patients with idiopathic thrombocytopenic purpura. IX International Symposium on Viral Hepatitis and Liver Disease 1996; C221: 259A
112. Hibbs JR, Frickhofen JM, Rosenfeld SJ et al. Aplastic anemia and viral hepatitis non-A, non-B, non-C. J Amer Med Ass 1992; 267: 2051-4
113. Byrnes JJ, Banks AT, Piatack Jr M, Kim JP, Hepatitis G associated aplastic anaemia. Lancet 1996; 348: 472 (letter)
114. Zaidi Y, Chapman CS, Myint S. Aplastic anaemia after HGV infection. Lancet 1995; 346: 471-2 (letter)
115. Brown KE, Tisdale J, Barrett J, Dunbar CE, Young NS. Hepatitis-associated aplastic anemia. N Engl J Med 1997; 336: 1059-64
116. Papaevangelou V, Span ou E, Kattamis C, Hadziyannis S. GBV-C infection in multiply transfused thalassemia patients with chronic non A-E hepatitis. J Hepatol 1997; 26 (suppl. 1) 91A
117. Zignego AL, Ferri C, Giannini C et al. HGV infection in B-cell non-Hodgkin's lymphoma. J Hepatol 1997; 26 (suppl 1): 79A
118. Berg T, Klein R, Zanger U, Hopf U, Berg PA. Relation between hepatitis G and anti-LKM1 positive autoimmune hepatitis type II (AIH II). J Hepatol 1997; 26 (suppl. 1): 180A
119. Fargion S, Sampietro M, Fracanzani AL et al. Hepatitis G virus (HGV) in patients with porphyria cutanea tarda (PCT). J Hepatol 1997; 26 (suppl 1): 207A